诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVAX 诺瓦瓦克斯医药

盘后交易 05-15 17:00:50 EDT

6.29

+0.33

+5.54%

盘后6.27

-0.02-0.32%

17:00 EDT

最高6.36	最低5.96	成交量997.74万
今开5.98	昨收5.96	日振幅6.63%
总市值10.19亿	流通市值8.59亿	总股本1.62亿
成交额6,202万	换手率7.30%	流通股本1.37亿
市净率-13.47	ROE-898.20%	每股收益2.97
52周最高23.86	52周最低5.01	市盈率2.11
股息0.00	股息收益率0.00	ROA19.97%

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"诺瓦瓦克斯医药","latestPrice":6.29,"timestamp":1747339200000,"preClose":5.96,"halted":0,"volume":9977413,"hourTrading":{"tag":"盘后","latestPrice":6.27,"preClose":6.29,"latestTime":"17:00 EDT","volume":42883,"amount":269771.24956100003,"timestamp":1747342845020},"delay":0,"floatShares":136603450,"shares":161970338,"eps":2.974266,"marketStatus":"盘后交易","change":0.33,"latestTime":"05-15 17:00:48 EDT","open":5.98,"high":6.355,"low":5.96,"amount":62020157.943128,"amplitude":0.066275,"askPrice":6.3,"askSize":900,"bidPrice":6.25,"bidSize":500,"shortable":3,"etf":0,"ttmEps":2.974266,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747353600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.96,"preHourTrading":{"tag":"盘前","latestPrice":5.99,"preClose":5.96,"latestTime":"09:27 EDT","volume":35159,"amount":211147.4202067,"timestamp":1747315670020},"postHourTrading":{"tag":"盘后","latestPrice":6.27,"preClose":6.29,"latestTime":"17:00 EDT","volume":42883,"amount":269771.24956100003,"timestamp":1747342845020},"volumeRatio":0.613492,"impliedVol":0.8329,"impliedVolPercentile":0.052},"requestUrl":"/m/hq/s/NVAX","defaultTab":"news","newsList":[{"id":"2535873360","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535873360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535873360?lang=zh_cn&edition=full","pubTime":"2025-05-15 23:47","pubTimestamp":1747324028,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日23时47分，诺瓦瓦克斯医药股票出现异动，股价快速拉升5.03%。截至发稿，该股报6.26美元/股，成交量452.336万股，换手率2.79%，振幅4.95%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为1.34%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家从事疫苗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234708a47fc551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515234708a47fc551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4585","NVAX","BK4547","BK4588"],"gpt_icon":0},{"id":"2535032080","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535032080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535032080?lang=zh_cn&edition=full","pubTime":"2025-05-15 00:44","pubTimestamp":1747241074,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日00时44分，诺瓦瓦克斯医药股票出现波动，股价大幅跳水5.00%。截至发稿，该股报5.88美元/股，成交量389.613万股，换手率2.41%，振幅6.38%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为1.29%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家从事疫苗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515004434a47e6a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515004434a47e6a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4585","BK4588","BK4547","BK4568","BK4139"],"gpt_icon":1},{"id":"1157589110","title":"特朗普：将签署行政令，药价将立即降低30%-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157589110","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157589110?lang=zh_cn&edition=full","pubTime":"2025-05-12 07:13","pubTimestamp":1747005195,"startTime":"0","endTime":"0","summary":"美国总统特朗普就美国高药价问题在其社媒发帖称，多年来，制药/药品公司总是声称这是研发成本所致，而且毫无缘由地，所有这些成本都将由美国的“冤大头”独自承担。政治献金能创造“奇迹”，但对我以及共和党来说却行不通。我们要做正确的事，因此，我很高兴地宣布，明天上午9点（北京时间周一21点），我将在白宫签署一项美国历史上影响极为深远的行政命令。处方药和药品价格几乎会立即下降30%至80%。全球药价将会上涨以达到平衡，多年来首次为美国带来公平！我将推行“最惠国”政策，据此美国将支付与世界上支付最低价格的国家相同的价格。此前，特朗普预告，其将发布最重要、最具影响力的内容之一。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"613df4b61bc3692be0fcc4204cdfad36","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash.jin10.com/detail/20250512063138170800","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jssj","symbols":["PFE","JNJ","MRK","NVO","NVAX","LLY","MRNA","NVS"],"gpt_icon":0},{"id":"2534463610","title":"小摩：维持Novavax(NVAX.US)评级，由减持调整至减持评级, 目标价由9.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534463610","media":"金融界","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534463610?lang=zh_cn&edition=full","pubTime":"2025-05-10 04:42","pubTimestamp":1746823350,"startTime":"0","endTime":"0","summary":"小摩：维持Novavax(NVAX.US)评级，由减持调整至减持评级, 目标价由9.00美元调整至7.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"21dd4c65ed62dccfde37add730729881","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10044250281494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NVAX"],"gpt_icon":0},{"id":"2534554480","title":"诺瓦瓦克斯医药盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534554480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534554480?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:42","pubTimestamp":1746798149,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时42分，诺瓦瓦克斯医药股票出现异动，股价快速下跌5.09%。截至发稿，该股报6.32美元/股，成交量141.137万股，换手率0.87%，振幅4.73%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，29%的券商给予持有建议，14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.46%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家从事疫苗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921422994f1d761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921422994f1d761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4585","BK4568","BK4547","BK4139","BK4588"],"gpt_icon":0},{"id":"2534118303","title":"诺瓦瓦克斯疫苗审批悬而未决，销售额却逆势猛增","url":"https://stock-news.laohu8.com/highlight/detail?id=2534118303","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534118303?lang=zh_cn&edition=full","pubTime":"2025-05-09 08:36","pubTimestamp":1746750967,"startTime":"0","endTime":"0","summary":"近日，该公司在第一季度财报中披露的销售数据引发热议，尽管其新冠疫苗在美国食品药品监督管理局的审批仍前途未卜，但销售额却实现了大幅增长。此外，诺瓦瓦克斯还对其疫苗的优势进行宣传。受这些积极因素影响，诺瓦瓦克斯将 2025 年全年收入预期从 9.75 亿美元上调至 10.3 亿美元 。诺瓦瓦克斯在疫苗审批和市场销售上呈现出的这种矛盾态势，凸显了疫苗行业面临的复杂局面。整个行业都在密切关注，期待诺瓦瓦克斯能给出答案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509092611a4776f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509092611a4776f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","HHS","BK4547","BK4139","BK4568","BK4588","BK4009","BK4585"],"gpt_icon":0},{"id":"1143414584","title":"异动解读 | 诺瓦瓦克斯医药盘前大涨9.24%，Q1转亏为盈超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1143414584","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143414584?lang=zh_cn&edition=full","pubTime":"2025-05-08 20:06","pubTimestamp":1746706004,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药今日盘前股价大涨9.24%，主要受益于公司第一季度财报好于预期。该公司成功扭亏为盈，这主要得益于其新冠疫苗相关支出的减少。展望未来，诺瓦瓦克斯上调了2025年的收入预期。值得注意的是，这一预期不包括与赛诺菲合作的销售额和特许权使用费。此外，公司正在与美国监管机构就其新冠疫苗的全面批准进行谈判，一旦获得批准，将从合作伙伴赛诺菲获得1.75亿美元的里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 诺瓦瓦克斯医药盘前大涨9.24%，Q1转亏为盈超预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2533258696","title":"美股抗疫概念股表现疲软，Moderna跌超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533258696","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533258696?lang=zh_cn&edition=full","pubTime":"2025-05-07 06:14","pubTimestamp":1746569668,"startTime":"0","endTime":"0","summary":"每经AI快讯，5月7日，美股抗疫概念股表现疲软，Moderna跌超12%，吉利德科学跌逾4%，诺瓦瓦克斯医药跌超3%，BioNTech跌逾6%，阿斯利康跌超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505073397198798.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505073397198798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2087621335.USD","IE0002270589.USD","LU1430594728.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU0320765992.SGD","BK4547","LU1066051498.USD","LU1674673691.USD","BK4566","LU0109394709.USD","BK4532","LU1839511570.USD","LU2468319806.SGD","BK4588","IE00B19Z3B42.SGD","NVAX","LU1778281490.HKD","BK4578","IE00B3T34201.USD","LU1674673428.USD","BK4583","BK4585","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2089984988.USD","LU1571399168.USD","IE00B19Z3581.USD","LU0289739699.SGD","GILD","BK4568","BK4139","LU0058720904.USD","LU1585245621.USD","BK4550","LU1066053197.SGD"],"gpt_icon":0},{"id":"2533579216","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.26%报5.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533579216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533579216?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:44","pubTimestamp":1746549851,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时44分，诺瓦瓦克斯医药股票出现异动，股价快速跳水5.26%。截至发稿，该股报5.94美元/股，成交量284.182万股，换手率1.75%，振幅5.42%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，29%的券商给予持有建议，14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为5.33%。公司认为其疫苗技术有潜力广泛应用于多种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004411a4744122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004411a4744122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","NVAX","BK4547","BK4588","BK4585"],"gpt_icon":0},{"id":"2533564107","title":"美股抗疫概念股多数下跌，BioNTech跌逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533564107","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533564107?lang=zh_cn&edition=full","pubTime":"2025-05-06 06:00","pubTimestamp":1746482434,"startTime":"0","endTime":"0","summary":"每经AI快讯，5月6日，美股抗疫概念股多数下跌，Moderna涨0.83%，吉利德科学跌0.84%，诺瓦瓦克斯医药跌超2%，BioNTech跌逾3%，阿斯利康跌0.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505063395982754.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505063395982754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BKVL7J92.USD","NVAX","IE00B19Z3581.USD","LU0058720904.USD","LU2087621335.USD","IE0002270589.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","BK4578","LU1571399168.USD","LU2089984988.USD","BK4585","LU1839511570.USD","BK4566","IE00BSNM7G36.USD","LU0320765992.SGD","LU1430594728.SGD","LU0289739699.SGD","BK4583","BK4588","BK4550","LU0109394709.USD","BK4568","LU1066051498.USD","LU2468319806.SGD","BK4139","LU0234570918.USD","LU1066053197.SGD","BK4547","LU0889565916.HKD","IE00B3T34201.USD","BK4532","IE00B19Z3B42.SGD","GILD"],"gpt_icon":0},{"id":"2530835286","title":"诺瓦瓦克斯医药盘中异动 快速拉升5.10%报7.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530835286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530835286?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:31","pubTimestamp":1745847078,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，诺瓦瓦克斯医药股票出现异动，股价大幅拉升5.10%。截至发稿，该股报7.01美元/股，成交量27.4853万股，换手率0.17%，振幅0.30%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1124.08%、302.99%、60.94%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Vaxart, Inc. - Common Stock、Fibrobiologics, Inc.，振幅分别为7.64%、5.71%、5.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213118a46a8dc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213118a46a8dc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","NVAX","BK4588","BK4585","BK4547"],"gpt_icon":1},{"id":"2530164896","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530164896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530164896?lang=zh_cn&edition=full","pubTime":"2025-04-26 03:20","pubTimestamp":1745608845,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日03时20分，诺瓦瓦克斯医药股票出现波动，股价大幅下挫5.73%。截至发稿，该股报6.67美元/股，成交量431.707万股，换手率2.68%，振幅6.42%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，29%的券商给予持有建议，14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为0.11%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家从事疫苗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426032045a6c86d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426032045a6c86d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4547","BK4585","NVAX","BK4568"],"gpt_icon":1},{"id":"1182748363","title":"异动解读 | 诺瓦瓦克斯医药股价盘中大跌5.02%，FDA延迟批准其新冠疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1182748363","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182748363?lang=zh_cn&edition=full","pubTime":"2025-04-24 22:06","pubTimestamp":1745503608,"startTime":"0","endTime":"0","summary":"周四盘中，诺瓦瓦克斯医药股价大跌5.02%，引发市场关注。这一跌势与美国食品和药物管理局延迟批准该公司新冠疫苗的消息密切相关。据报道，FDA要求诺瓦瓦克斯提供更多临床数据，以证明其新冠疫苗的有效性。尽管FDA的决定带来了挑战，但诺瓦瓦克斯表示，根据与FDA的沟通结果，公司认为其申请\"可以批准\"，只是需要在批准后提供更多数据。然而，由于现有批次的诺瓦瓦克斯疫苗将于4月30日到期，公司面临着时间压力。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 诺瓦瓦克斯医药股价盘中大跌5.02%，FDA延迟批准其新冠疫苗","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2529664245","title":"美股抗疫概念股全线上涨，诺瓦瓦克斯医药涨近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529664245","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529664245?lang=zh_cn&edition=full","pubTime":"2025-04-24 05:56","pubTimestamp":1745445361,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月24日，美股抗疫概念股全线上涨，Moderna涨超3%，吉利德科学涨0.82%，诺瓦瓦克斯医药涨近20%，BioNTech涨近10%，阿斯利康涨近1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504243386344737.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504243386344737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4547","BK4588","BK4139","NVAX","BK4585","BK4568"],"gpt_icon":0},{"id":"1126942168","title":"异动解读 | 诺瓦瓦克斯医药盘中大涨17.28%，疫苗获批前景乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1126942168","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126942168?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:43","pubTimestamp":1745415780,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药今日盘中大涨17.28%，引发市场广泛关注。这一显著涨幅主要源于该公司与美国食品药品监督管理局就其新冠疫苗批准事宜的最新进展。根据诺瓦瓦克斯医药的声明，FDA已要求公司承诺在其新冠疫苗获得批准后提供更多临床数据。这一消息大大增强了投资者对公司疫苗最终获批的信心。市场分析人士认为，如果诺瓦瓦克斯的新冠疫苗最终获得FDA的批准，将对公司未来的业务发展和市场地位产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX"],"gpt_icon":0},{"id":"2529768600","title":"诺瓦瓦克斯医药(NVAX.O)股价上涨15%，公司称COVID-19疫苗已获批准。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529768600","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529768600?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:32","pubTimestamp":1745415130,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4535","159646","BK4588","BNTX","BK4551","BK4568","BK4548","BK4139","NVAX","BK4585","BK4547"],"gpt_icon":0},{"id":"1154849549","title":"异动解读 | 诺瓦瓦克斯医药盘前大涨13.72%，FDA要求提供新冠疫苗额外数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1154849549","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154849549?lang=zh_cn&edition=full","pubTime":"2025-04-23 20:30","pubTimestamp":1745411448,"startTime":"0","endTime":"0","summary":"周三盘前，诺瓦瓦克斯医药股价大涨13.72%，引发市场关注。这一显著涨幅主要源于该公司与美国食品药品监督管理局就其新冠疫苗批准事宜的最新进展。根据诺瓦瓦克斯医药的声明，FDA已要求公司承诺在其新冠疫苗获得批准后提供更多临床数据。市场分析人士认为，如果诺瓦瓦克斯的新冠疫苗最终获得FDA的批准，将对公司未来的业务发展和市场地位产生积极影响。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 诺瓦瓦克斯医药盘前大涨13.72%，FDA要求提供新冠疫苗额外数据","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2529688210","title":"诺瓦瓦克斯医药美股盘前上涨14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529688210","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529688210?lang=zh_cn&edition=full","pubTime":"2025-04-23 20:27","pubTimestamp":1745411239,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药美股盘前上涨14%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504233386075983.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504233386075983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4547","BK4568","BK4585","BK4588","NVAX","BK4139"],"gpt_icon":0},{"id":"1138965294","title":"诺瓦瓦克斯医药盘前直线拉升，新冠疫苗上市事宜有新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1138965294","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138965294?lang=zh_cn&edition=full","pubTime":"2025-04-23 20:22","pubTimestamp":1745410962,"startTime":"0","endTime":"0","summary":"公司认为其上市申请\"可以批准\"。","market":"us","thumbnail":"https://static.tigerbbs.com/1c1f4cb5e5175a7fb9b818e6ef6c215d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1c1f4cb5e5175a7fb9b818e6ef6c215d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX"],"gpt_icon":0},{"id":"2529502769","title":"诺瓦瓦克斯医药(NVAX.O)盘前上涨14%，公司称美国食品药品监督管理局（FDA）在批准其新冠疫苗后要求提供额外数据。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529502769","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529502769?lang=zh_cn&edition=full","pubTime":"2025-04-23 20:16","pubTimestamp":1745410613,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["NVAX","BK4568","BK4139","BK4588","BK4547","159646","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":-0.0702},{"period":"3month","weight":-0.2714},{"period":"6month","weight":-0.1858},{"period":"1year","weight":-0.5579},{"period":"ytd","weight":-0.2587}],"compareEarnings":[{"period":"1week","weight":0.0471},{"period":"1month","weight":0.0899},{"period":"3month","weight":-0.0363},{"period":"6month","weight":0.0031},{"period":"1year","weight":0.1229},{"period":"ytd","weight":0.0026}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novavax, Inc.于1987年根据美国特拉华州法律注册成立，是一家临床阶段的生物制药公司，专注于重组纳米颗粒疫苗和佐剂的发现、开发和商业化。该公司的疫苗技术平台基于包括病毒样颗粒（VLP）和蛋白质纳米颗粒候选疫苗的专有重组纳米颗粒疫苗技术。该公司的候选疫苗是基因工程的三维纳米结构，其中包含了免疫学上重要的蛋白质。公司的疫苗产品管线针对多种传染病，候选药物目前处于呼吸道合胞病毒（RSV）、季节性流感、大流行性流感的临床开发阶段。此外，该公司在印度的合资公司CPL Biologics Private Limited（CPLB）正在积极开发多款候选疫苗，这些候选疫苗由诺瓦瓦克斯医药进行基因工程改造。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.101177},{"month":2,"riseRate":0.566667,"avgChangeRate":0.039349},{"month":3,"riseRate":0.266667,"avgChangeRate":-0.040904},{"month":4,"riseRate":0.466667,"avgChangeRate":0.00903},{"month":5,"riseRate":0.5,"avgChangeRate":0.11911},{"month":6,"riseRate":0.517241,"avgChangeRate":0.09837},{"month":7,"riseRate":0.551724,"avgChangeRate":0.018176},{"month":8,"riseRate":0.517241,"avgChangeRate":0.037008},{"month":9,"riseRate":0.482759,"avgChangeRate":-0.043221},{"month":10,"riseRate":0.310345,"avgChangeRate":0.029378},{"month":11,"riseRate":0.344828,"avgChangeRate":0.002076},{"month":12,"riseRate":0.37931,"avgChangeRate":-0.038326}],"exchange":"NASDAQ","name":"诺瓦瓦克斯医药","nameEN":"Novavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺瓦瓦克斯医药,NVAX,诺瓦瓦克斯医药股票,诺瓦瓦克斯医药股票老虎,诺瓦瓦克斯医药股票老虎国际,诺瓦瓦克斯医药行情,诺瓦瓦克斯医药股票行情,诺瓦瓦克斯医药股价,诺瓦瓦克斯医药股市,诺瓦瓦克斯医药股票价格,诺瓦瓦克斯医药股票交易,诺瓦瓦克斯医药股票购买,诺瓦瓦克斯医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}